FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285586708> ?p ?o ?g. }

• W4285586708 endingPage "e114" @default.
• W4285586708 startingPage "e105" @default.
• W4285586708 abstract "Objective: We examined the effects of dexamethasone on postoperative mortality, recurrence-free survival, and side effects in patients undergoing oncologic operations. Background: Dexamethasone prevents nausea and vomiting after anesthesia and may affect cancer proliferation. Methods: A total of 30,561 adult patients undergoing solid cancer resection between 2005 and 2020 were included. Multivariable logistic regression was applied to investigate the effect of dexamethasone on 1-year mortality and recurrence-free survival. Effect modification by the cancer’s potential for immunogenicity, defined as a recommendation for checkpoint inhibitor therapy based on the National Comprehensive Cancer Network guidelines, was investigated through interaction term analysis. Key safety endpoints were dexamethasone-associated risk of hyperglycemia >180 mg/dL within 24 hours and surgical site infections within 30 days after surgery. Results: Dexamethasone was administered to 38.2% (11,666/30,561) of patients (6.5±2.3 mg). Overall, 3.2% (n=980/30,561) died and 15.4% (n=4718/30,561) experienced cancer recurrence within 1 year of the operation. Dexamethasone was associated with a −0.6% (95% confidence interval: −1.1, −0.2, P =0.007) 1-year mortality risk reduction [adjusted odds ratio (OR adj ): 0.79 (0.67, 0.94), P =0.009; hazard ratio=0.82 (0.69, 0.96), P =0.016] and higher odds of recurrence-free survival [OR adj : 1.28 (1.18, 1.39), P <0.001]. This effect was only present in patients with solid cancers who were defined as not to respond to checkpoint inhibitor therapy [OR adj : 0.70 (0.57, 0.87), P =0.001 vs OR adj : 1.13 (0.85, 1.50), P =0.40]. A high (>0.09 mg/kg) dose of dexamethasone increased the risk of postoperative hyperglycemia [OR adj : 1.55 (1.32, 1.82), P <0.001], but not for surgical site infections [OR adj : 0.84 (0.42, 1.71), P =0.63]. Conclusions: Dexamethasone is associated with decreased 1-year mortality and cancer recurrence in patients undergoing surgical resection of cancers that are not candidates for immune modulators. Dexamethasone increased the risk of postoperative hyperglycemia, however, no increase in surgical site infections was identified." @default.
• W4285586708 created "2022-07-16" @default.
• W4285586708 creator A5010291166 @default.
• W4285586708 creator A5023999243 @default.
• W4285586708 creator A5025353854 @default.
• W4285586708 creator A5036552402 @default.
• W4285586708 creator A5044819841 @default.
• W4285586708 creator A5045289131 @default.
• W4285586708 creator A5060194304 @default.
• W4285586708 creator A5061627885 @default.
• W4285586708 creator A5064040959 @default.
• W4285586708 creator A5065631511 @default.
• W4285586708 creator A5072054125 @default.
• W4285586708 creator A5088922500 @default.
• W4285586708 date "2022-07-18" @default.
• W4285586708 modified "2023-09-25" @default.
• W4285586708 title "Association Between Intraoperative Dexamethasone and Postoperative Mortality in Patients Undergoing Oncologic Surgery" @default.
• W4285586708 cites W1985118454 @default.
• W4285586708 cites W1990886153 @default.
• W4285586708 cites W2000445173 @default.
• W4285586708 cites W2006835947 @default.
• W4285586708 cites W2030022984 @default.
• W4285586708 cites W2037960569 @default.
• W4285586708 cites W2061326496 @default.
• W4285586708 cites W2074573138 @default.
• W4285586708 cites W2079839878 @default.
• W4285586708 cites W2088828093 @default.
• W4285586708 cites W2132534346 @default.
• W4285586708 cites W2133055382 @default.
• W4285586708 cites W2134865287 @default.
• W4285586708 cites W2148541864 @default.
• W4285586708 cites W2152051888 @default.
• W4285586708 cites W2166516950 @default.
• W4285586708 cites W2172081661 @default.
• W4285586708 cites W2190351741 @default.
• W4285586708 cites W2241445697 @default.
• W4285586708 cites W2275737843 @default.
• W4285586708 cites W2314371607 @default.
• W4285586708 cites W2314957028 @default.
• W4285586708 cites W2323697724 @default.
• W4285586708 cites W2582059990 @default.
• W4285586708 cites W2593041928 @default.
• W4285586708 cites W2601644616 @default.
• W4285586708 cites W2626749754 @default.
• W4285586708 cites W2783300111 @default.
• W4285586708 cites W2793566526 @default.
• W4285586708 cites W2806857881 @default.
• W4285586708 cites W2807901909 @default.
• W4285586708 cites W2896343057 @default.
• W4285586708 cites W2912525446 @default.
• W4285586708 cites W2947279574 @default.
• W4285586708 cites W2953312164 @default.
• W4285586708 cites W2979776638 @default.
• W4285586708 cites W2998030715 @default.
• W4285586708 cites W2998452836 @default.
• W4285586708 cites W3014295435 @default.
• W4285586708 cites W3014484249 @default.
• W4285586708 cites W3038587648 @default.
• W4285586708 cites W3091992897 @default.
• W4285586708 cites W3104608497 @default.
• W4285586708 cites W3123523652 @default.
• W4285586708 cites W3135861526 @default.
• W4285586708 cites W3157134006 @default.
• W4285586708 cites W3195951788 @default.
• W4285586708 cites W4226154520 @default.
• W4285586708 doi "https://doi.org/10.1097/sla.0000000000005526" @default.
• W4285586708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35837889" @default.
• W4285586708 hasPublicationYear "2022" @default.
• W4285586708 type Work @default.
• W4285586708 citedByCount "2" @default.
• W4285586708 countsByYear W42855867082023 @default.
• W4285586708 crossrefType "journal-article" @default.
• W4285586708 hasAuthorship W4285586708A5010291166 @default.
• W4285586708 hasAuthorship W4285586708A5023999243 @default.
• W4285586708 hasAuthorship W4285586708A5025353854 @default.
• W4285586708 hasAuthorship W4285586708A5036552402 @default.
• W4285586708 hasAuthorship W4285586708A5044819841 @default.
• W4285586708 hasAuthorship W4285586708A5045289131 @default.
• W4285586708 hasAuthorship W4285586708A5060194304 @default.
• W4285586708 hasAuthorship W4285586708A5061627885 @default.
• W4285586708 hasAuthorship W4285586708A5064040959 @default.
• W4285586708 hasAuthorship W4285586708A5065631511 @default.
• W4285586708 hasAuthorship W4285586708A5072054125 @default.
• W4285586708 hasAuthorship W4285586708A5088922500 @default.
• W4285586708 hasConcept C121608353 @default.
• W4285586708 hasConcept C126322002 @default.
• W4285586708 hasConcept C141071460 @default.
• W4285586708 hasConcept C156957248 @default.
• W4285586708 hasConcept C207103383 @default.
• W4285586708 hasConcept C2780401358 @default.
• W4285586708 hasConcept C2780580376 @default.
• W4285586708 hasConcept C2780852908 @default.
• W4285586708 hasConcept C44249647 @default.
• W4285586708 hasConcept C71924100 @default.
• W4285586708 hasConceptScore W4285586708C121608353 @default.
• W4285586708 hasConceptScore W4285586708C126322002 @default.
• W4285586708 hasConceptScore W4285586708C141071460 @default.
• W4285586708 hasConceptScore W4285586708C156957248 @default.

• next